Lonza Group, a chemical and biotech company headquartered in Switzerland, continued its China expansion by completing the start-up of the second phase of its large-scale API facility in Nansha, a district of Guangzhou. The facility combines development services and cGMP chemical manufacturing. The new plant also includes facilities for administration, R&D, a kilo lab, and both small- and large-scale production. Seventy scientists provide R&D services in 1,000 square meters of lab space. More details...